USS Investment Management Ltd Lowers Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• USS Investment Management Ltd has reduced its holdings in GE HealthCare Technologies Inc. by 15.3%, now owning 81,290 shares valued at $6.56 million.
• Several hedge funds have increased their stakes in GE HealthCare, with JPMorgan Chase & Co. boosting its holdings by 49.9% during the first quarter.
• GE HealthCare reported quarterly earnings of $1.06 per share, surpassing analyst estimates of $0.91, alongside a revenue of $5 billion.

USS Investment Management Ltd lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 15.3% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 81,290 shares of the company's stock after selling 14,700 shares during the period. USS Investment Management Ltd's holdings in GE HealthCare Technologies were worth $6,558,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter worth about $25,000. Bogart Wealth LLC lifted its position in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after buying an additional 247 shares in the last quarter. Stonebridge Financial Group LLC boosted its stake in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after buying an additional 222 shares during the period. Ameriflex Group Inc. purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at $31,000. Finally, Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter worth $35,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on GEHC shares. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. Morgan Stanley dropped their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Finally, Citigroup boosted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded down $2.72 during midday trading on Wednesday, reaching $75.99. The stock had a trading volume of 4,102,538 shares, compared to its average volume of 2,832,072. The firm has a market cap of $34.69 billion, a PE ratio of 15.57, a P/E/G ratio of 3.01 and a beta of 1.13. The firm has a 50 day simple moving average of $74.41 and a 200-day simple moving average of $73.85. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business's revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.